ramipril krka 2,5 mg
krka, d.d., novo mesto, slovinsko - ramipril - 58 - hypotensiva
galliapharm
eckert & ziegler radiopharma gmbh, nemecko - iné diagnostické rádiofarmaká - 88 - radiopharmaca
premed 300 mg
cande s.r.o., slovensko - pregabalín - 21 - antiepileptica, anticonvulsiva
premed 150 mg
cande s.r.o., slovensko - pregabalín - 21 - antiepileptica, anticonvulsiva
premed 75 mg
cande s.r.o., slovensko - pregabalín - 21 - antiepileptica, anticonvulsiva
dutasterid cipla 0,5 mg mäkké kapsuly
cipla europe nv, belgicko - dutasterid - 87 - varia i
dutasterid mylan 0,5 mg
mylan ireland limited - dutasterid - 87 - varia i
verzenios
eli lilly nederland b.v. - abemaciclib - neoplazmy prsníkov - antineoplastické činidlá - early breast cancerverzenios in combination with endocrine therapy is indicated for the adjuvant treatment of adult patients with hormone receptor (hr) positive, human epidermal growth factor receptor 2 (her2) negative, node positive early breast cancer at high risk of recurrence (see section 5. in pre or perimenopausal women, aromatase inhibitor endocrine therapy should be combined with a luteinising hormone-releasing hormone (lhrh) agonist. advanced or metastatic breast cancerverzenios is indicated for the treatment of women with hormone receptor (hr) positive, human epidermal growth factor receptor 2 (her2) negative locally advanced or metastatic breast cancer in combination with an aromatase inhibitor or fulvestrant as initial endocrine-based therapy, or in women who have received prior endocrine therapy. in pre- or perimenopausal women, the endocrine therapy should be combined with a lhrh agonist.
pexapral 3,15 mg tablety s predĺženým uvoľňovaním
neuraxpharm bohemia s.r.o., Česká republika - pramipexol - 27 - antiparkinsonica